| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $360.5M | -48.0% |
| Cost of Revenue | $165.7M | -46.1% |
| Gross Profit | $194.8M | -49.5% |
| R&D Expense | $225.2M | -16.4% |
| SG&A Expense | $138.3M | +4.7% |
| Operating Income | -$223.4M | -484.4% |
| Pre-tax Income | -$238.7M | -274.1% |
| Income Tax | $6.5M | -30.6% |
| Net Income | -$245.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $118.6M | -36.7% |
| Accounts Receivable | $85.5M | -49.9% |
| Inventory | $90.3M | -9.6% |
| Current Assets | $323.4M | -33.7% |
| Total Assets | $864.6M | -20.0% |
| Current Liabilities | $182.3M | -17.9% |
| Long-term Debt | $123.0M | +0.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.3M | -204.4% |
| Capital Expenditures | $17.7M | +31.4% |
| Investing Cash Flow | -$23.4M | -47.1% |
| Financing Cash Flow | $1.3M | +104.9% |
| Free Cash Flow | -$63.0M | -310.5% |
| -235.2% |
| EPS (Basic) | -$2.93 | -222.0% |
| EPS (Diluted) | -$2.93 | -222.0% |
| Total Liabilities |
| $348.4M |
| -11.6% |
| Stockholders' Equity | $516.3M | -24.8% |